Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223

BACKGROUND: Radium-223 dichloride is an alpha emitter approved for metastatic castration-resistant prostate cancer (mCRPC). Unfortunately, little data are available on the prognostic factors during radium-223-based therapy. PATIENTS AND METHODS: Patients with histologically confirmed progressive CRP...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Roviello, Giandomenico, Gallicchio, Rosj, Bozza, Giovanni, Rodriquenz, Maria Grazia, Aieta, Michele, Storto, Giovanni
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2018
Fag:
Rapid Communication
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6301292/
https://ncbi.nlm.nih.gov/pubmed/30588025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S174206
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker